Silicon Laboratories Inc (SLAB)
Official siteTECHNOLOGY • SEMICONDUCTORS • NASDAQ
Market Cap: $7.39B
Last updated: Nov 17, 2026 at 11:06 AM ET
Silicon Laboratories Inc (SLAB) Financials: Revenue, Profit and Cash Flow
Silicon Laboratories reported revenue of $784.76M for the fiscal year ended Dec 31, 2025, up 34.3% from the year before. That year, net income was -$64.91M with a net margin of -8.3%, operating cash flow was $95.71M and free cash flow was $61.79M. The quarter ended Sep 30, 2026 had revenue of $250.89M and net income of $8.85M.
Revenue and Margins
The operating margin was -9.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $697.63M, a compound annual rate of 1.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $784.76M | +34.3% | 58.2% | -9.0% | -8.3% |
| Dec 2024 | $584.39M | -25.3% | 53.4% | -28.3% | -32.7% |
| Dec 2023 | $782.26M | -23.6% | 58.9% | -3.1% | -4.4% |
| Dec 2022 | $1.02B | +42.1% | 62.7% | 11.6% | 8.9% |
| Dec 2021 | $720.86M | +41.1% | 59.0% | -4.6% | 293.7% |
| Dec 2020 | $510.93M | +7.8% | 57.7% | -21.0% | 2.5% |
| Dec 2019 | $473.79M | -45.4% | 59.1% | -18.7% | 4.1% |
| Dec 2018 | $868.27M | +12.9% | 60.1% | 9.8% | 9.6% |
| Dec 2017 | $768.87M | +10.2% | 59.1% | 11.1% | 6.1% |
| Dec 2016 | $697.63M | N/A | 60.4% | 9.5% | 8.8% |
Income Statement
In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $784.76M | $584.39M | $782.26M | $1.02B | $720.86M | $510.93M | $473.79M | $868.27M | $768.87M | $697.63M |
| Cost of revenue | $327.78M | $272.20M | $321.67M | $381.55M | $295.47M | $216.08M | $193.57M | $346.87M | $314.68M | $276.12M |
| Gross profit | $456.98M | $312.19M | $460.59M | $642.56M | $425.39M | $294.85M | $280.21M | $521.40M | $454.19M | $421.50M |
| Research and development | $353.25M | $332.23M | $337.74M | $332.33M | $273.21M | $235.19M | $205.69M | $238.35M | $209.49M | $199.74M |
| Operating income | -$70.54M | -$165.49M | -$24.15M | $119.26M | -$32.84M | -$107.09M | -$88.64M | $85.21M | $84.97M | $66.28M |
| Net income | -$64.91M | -$191.01M | -$34.52M | $91.40M | $2.12B | $12.53M | $19.27M | $83.59M | $47.09M | $61.49M |
| EBITDA | -$32.46M | -$116.91M | $27.89M | $177.86M | $52.48M | -$26.82M | -$22.23M | $158.11M | $137.13M | $107.21M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $250.89M | $228.19M | $213.50M | $208.21M | $206.00M | $192.84M | $177.71M | $166.25M | $166.40M | $145.37M | $106.38M | $86.84M |
| Gross profit | $152.58M | $140.67M | $127.00M | $132.08M | $119.02M | $108.11M | $97.78M | $90.22M | $90.31M | $76.58M | $55.07M | $43.93M |
| Operating income | $7.95M | -$10.67M | -$17.08M | -$3.25M | -$12.34M | -$22.87M | -$32.08M | -$28.63M | -$29.71M | -$48.02M | -$59.13M | -$73.11M |
| Net income | $8.85M | -$10.59M | -$15.90M | -$2.68M | -$9.94M | -$21.82M | -$30.47M | -$23.82M | -$28.50M | -$82.16M | -$56.53M | -$69.79M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $0 by $364.22M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.27B | $1.22B | $1.44B | $2.17B | $2.96B | $1.99B | $1.67B | $1.62B | $1.54B | $1.08B |
| Current assets | $674.02M | $602.03M | $737.93M | $1.46B | $2.24B | $975.82M | $943.86M | $826.64M | $947.64M | $490.85M |
| Cash and equivalents | $364.22M | $281.61M | $227.50M | $499.92M | $1.07B | $202.72M | $227.15M | $197.04M | $269.37M | $141.11M |
| Total liabilities | $174.90M | $142.65M | $234.37M | $764.42M | $745.87M | $793.65M | $559.80M | $557.06M | $582.07M | $254.89M |
| Short-term debt | $0 | $5.88M | $45.00M | $0 | $450.60M | $134.48M | $0 | $5.29M | $341.88M | $72.50M |
| Long-term debt | N/A | N/A | $0 | $529.57M | $0 | $428.94M | $422.10M | $412.22M | $419.74M | $115.19M |
| Shareholder equity | $1.09B | $1.08B | $1.21B | $1.41B | $2.21B | $1.20B | $1.12B | $1.07B | $953.02M | $826.96M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.34B | $1.25B | $1.27B | $1.27B | $1.25B | $1.22B | $1.23B | $1.22B | $1.25B | $1.25B | $1.34B | $1.44B |
| Total liabilities | $210.77M | $158.25M | $167.93M | $174.90M | $182.35M | $159.99M | $161.08M | $142.65M | $167.86M | $156.96M | $178.59M | $234.37M |
| Cash and equivalents | $423.01M | $362.19M | $383.09M | $364.22M | $341.40M | $314.46M | $324.88M | $281.61M | $303.08M | $240.83M | $191.49M | $227.50M |
| Shareholder equity | $1.13B | $1.09B | $1.10B | $1.09B | $1.07B | $1.06B | $1.07B | $1.08B | $1.08B | $1.09B | $1.17B | $1.21B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 64.6% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $95.71M | -$13.91M | -$30.35M | $141.27M | $91.20M | -$8.84M | $22.18M | $173.54M | $189.52M | $128.91M |
| Capital expenditures | $33.92M | $11.75M | $22.80M | $26.52M | $29.73M | $19.30M | $23.23M | $35.52M | $17.21M | $19.73M |
| Free cash flow | $61.79M | -$25.66M | -$53.15M | $114.75M | $61.46M | -$28.14M | -$1.05M | $138.02M | $172.31M | $109.18M |
| Dividends paid | N/A | N/A | N/A | N/A | N/A | $845.00M | $1.13M | N/A | $0 | $0 |
| Share repurchases | $0 | $16.00K | $217.14M | $883.42M | $1.15B | $16.29M | $26.72M | $39.28M | $0 | $40.54M |
| Investing cash flow | -$12.03M | $113.12M | $469.81M | $240.54M | -$476.67M | -$358.32M | -$102.81M | -$197.03M | -$374.29M | -$49.58M |
| Financing cash flow | -$1.07M | -$45.10M | -$711.87M | -$887.05M | -$1.30B | $200.87M | -$29.65M | -$48.84M | $313.03M | -$52.30M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $46.78M | -$14.51M | $4.93M | $8.35M | $34.32M | $4.91M | $48.13M | $10.13M | $31.63M | $16.13M | -$71.80M | $18.54M |
| Capital expenditures | $6.32M | $12.32M | $9.84M | $13.98M | $6.39M | $8.70M | $4.85M | $3.96M | $2.21M | $3.53M | $2.05M | $3.87M |
| Free cash flow | $40.46M | -$26.83M | -$4.90M | -$5.63M | $27.93M | -$3.79M | $43.28M | $6.17M | $29.42M | $12.60M | -$73.85M | $14.66M |
Frequently Asked Questions About SLAB
What is Silicon Laboratories' annual revenue?
Silicon Laboratories reported revenue of $784.76M for the fiscal year ended Dec 31, 2025.
How fast is Silicon Laboratories' revenue growing?
Revenue was up 34.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -8.5%.
Is Silicon Laboratories profitable?
No. Silicon Laboratories reported net income of -$64.91M for the fiscal year ended Dec 31, 2025, with a net margin of -8.3%.
How much free cash flow does SLAB generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $95.71M minus capital expenditures of $33.92M produced free cash flow of $61.79M.
How much debt does Silicon Laboratories have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $0 and cash and equivalents of $364.22M.
SLAB pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors